P

Inventor

TURNER S DEREK

US40 patents
⚠️ This page may combine multiple inventors who share the name “TURNER S DEREK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

THERAVANCE INC

29 patents
US7655621B2Feb 2, 2010

Cross-linked glycopeptide-cephalosporin antibiotics

THERAVANCE INC26 citations96
US7649080B2Jan 19, 2010

Cross-linked glycopeptide-cephalosporin antibiotics

THERAVANCE INC24 citations96
US7601690B2Oct 13, 2009

Cross-linked glycopeptide-cephalosporin antibiotics

THERAVANCE INC25 citations96
US7375114B2May 20, 2008

Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

THERAVANCE INC41 citations96
US7341993B2Mar 11, 2008

Cross-linked glycopeptide—cephalosporin antibiotics

THERAVANCE INC22 citations96
US6974797B2Dec 13, 2005

Cross-linked glycopeptide-cephalosporin antibiotics

THERAVANCE INC45 citations96
US6878686B2Apr 12, 2005

Cross-linked glycopeptide-cephalosporin antibiotics

THERAVANCE INC49 citations96
US7728127B2Jun 1, 2010

Cross-linked glycopeptide-cephalosporin antibiotics

THERAVANCE INC20 citations93
US7612037B2Nov 3, 2009

Cross-linked glycopeptide-cephalosporin antibiotics

THERAVANCE INC18 citations93
US7592355B2Sep 22, 2009

Quinolinone-carboxamide compounds as 5-HT, receptor agonists

THERAVANCE INC13 citations93
US7553962B2Jun 30, 2009

Cross-linked glycopeptide-cephalosporin antibiotics

THERAVANCE INC21 citations93
US7317022B2Jan 8, 2008

Benzoimidazolone-carboxamide compounds as 5-HT4 receptors agonists

THERAVANCE INC19 citations93
US7763637B2Jul 27, 2010

Quinolinone-carboxamide compounds as 5-HT4, receptor agonists

THERAVANCE INC12 citations92
US7419989B2Sep 2, 2008

Indazole-carboxamide compounds

THERAVANCE INC19 citations92
US7399862B2Jul 15, 2008

5-HT4 receptor agonist compounds

THERAVANCE INC26 citations92
US7351704B2Apr 1, 2008

Indazole-carboxamide compounds as 5-HT4 receptor agonists

THERAVANCE INC25 citations92
US7183323B2Feb 27, 2007

Sodium channel modulators

THERAVANCE INC20 citations92
US6995138B2Feb 7, 2006

Cross-linked glycopeptide-cephalosporin antibiotics

THERAVANCE INC34 citations92
US6756400B2Jun 29, 2004

Sodium channel modulators

THERAVANCE INC36 citations92
US7728006B2Jun 1, 2010

Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

THERAVANCE INC11 citations84
US7534889B2May 19, 2009

5-HT4 receptor agonist compounds

THERAVANCE INC13 citations84
US7446114B2Nov 4, 2008

Quinolinone compounds as 5-HT4 receptor agonists

THERAVANCE INC10 citations84
US7713931B2May 11, 2010

Cross-linked glycopeptide-cephalosporin antibiotics

THERAVANCE INC7 citations82
US7875629B2Jan 25, 2011

Quinolinone compounds as 5-HT4 receptor agonists

THERAVANCE INC6 citations74
US7728004B2Jun 1, 2010

Crystalline form of a quinolinone-carboxamide compound

THERAVANCE INC6 citations73
US7772239B2Aug 10, 2010

Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonists

THERAVANCE INC4 citations63
US8044045B2Oct 25, 2011

Indazole-carboxamide compounds as 5-HT4 receptor agonists

THERAVANCE INC1 citations52
US8003664B2Aug 23, 2011

Indazole-carboxamide compounds

THERAVANCE INC0 citations52
US7786136B2Aug 31, 2010

Indazole-carboxamide compounds

THERAVANCE INC0 citations52

MARQUESS DANIEL

6 patents

FATHEREE PAUL R

3 patents

THERAVANCE BIOPHARMA R&D IP LLC

2 patents